Impact of Tailored Preventive Exercise Program for Reducing Risk of Hip Adductors Injury
Launched by CAIRO UNIVERSITY · Nov 15, 2024
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special exercise program designed to prevent injuries to the hip muscles (specifically, the hip adductors) in professional male football players. The goal is to see if this tailored program can help players keep their strength, reduce pain during games, and improve their overall groin health and performance on the field.
To participate in this trial, players must be male football players who have experienced a noticeable decrease in strength in their hip adductor muscles and have a specific imbalance in strength between their adductor and abductor muscles. They should also have mild muscle fatigue or pain during or after matches but no serious injuries. Participants will receive a complete review of their groin health and injury history before starting the program. It's important to note that players with current injuries in the hip area or who aren't actively playing will not be eligible for this study.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male football players only will be included in the study. Men's football had the second highest injury rates .
- • Players will have loss in hip adductor strength more than 15% .
- • Players will have hip adductor/abductor strength ratio in percent less than 80% or ratio less than 0.9.
- • Participants will go under full documentation of groin health and injury history.
- • Participants will Complain of muscle fatigue or spasm or mild pain on VAS will be 3 or less, during and after matches with no real injury.
- Exclusion Criteria:
- • Presence of injuries at the level of the hip/hip region at the initial assessment
- • Players with acute groin injuries.
- • Players with recent hip and pelvic floor muscles problems.
- • Players with acute hip adductor strains or tears.
- • Players with inguinal hernia.
- • Players who already don't play matches or stop training.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Sohair shehata
Study Chair
Cairo University
Magda Ramadan, professor
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported